Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about SNY

Recent news which mentions SNY

...

11 12 13 14 15 16 17 18 19

...

Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing

May 12, 2023

Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody

May 12, 2023

Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate

May 11, 2023

Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics

May 10, 2023

7 Blue-Chip Stocks to Buy in May 2023

May 04, 2023

Why Regeneron Pharmaceuticals Shares Are Trading Lower Today

May 04, 2023

7 Stock Upgrades and Downgrades Alerts You Cannot Ignore

May 04, 2023

First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories

May 01, 2023

European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals

May 01, 2023

Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront

May 01, 2023

Sanofi (SNY) Q1 2023 Earnings Call Transcript

April 28, 2023

Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales

April 27, 2023

Earnings Scheduled For April 27, 2023

April 27, 2023

US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'

April 27, 2023

Earnings Outlook For Sanofi

April 26, 2023

Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz

April 24, 2023

United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review

April 21, 2023

Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis

April 19, 2023

Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So

April 18, 2023

Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise

April 12, 2023

Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information

April 11, 2023

Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow

April 11, 2023

Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow

April 11, 2023

2 Top Healthcare Stocks Defying the Bear Market

April 07, 2023

Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market

April 06, 2023

Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?

March 30, 2023

Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?

March 25, 2023

Is Sanofi Stock a Buy Now?

March 25, 2023

Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In

March 24, 2023

Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration

March 24, 2023

...

11 12 13 14 15 16 17 18 19

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.